Cargando…
The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that is characterized by abdominal pain and disordered bowel habits. The etiology of IBS is multifactorial, including abnormal gut-brain interactions, visceral hypersensitivity, altered colon motility, and psychological factors...
Autores principales: | Jiang, Wenxi, Wu, Jiali, Zhu, Shefeng, Xin, Linying, Yu, Chaohui, Shen, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Neurogastroenterology and Motility
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577580/ https://www.ncbi.nlm.nih.gov/pubmed/36250361 http://dx.doi.org/10.5056/jnm22093 |
Ejemplares similares
-
Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
por: Farup, Per G., et al.
Publicado: (2016) -
Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome
por: Shaidullov, Ilnar F., et al.
Publicado: (2021) -
Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients
por: Sun, Qing Hua, et al.
Publicado: (2021) -
Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis
por: Luo, Mei, et al.
Publicado: (2021) -
Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)